IP Library Granted Patent US 10,143,846
Granted Patent B2
US 10,143,846 · App. 15/828,950 · Granted Dec 4, 2018

Systems and methods for treatment of dry eye

Inventors: Douglas Michael Ackermann (San Francisco, CA); Daniel Palanker (Palo Alto, CA); James Donald Loudin (Houston, TX); Garrett Cale Smith (San Francisco, CA); Victor Wayne McCray (San Jose, CA); Brandon McNary Felkins (Half Moon Bay, CA)
Assignee: The Board of Trustees of the Leland Stanford Junior University
A61N1/37205A61N1/3606A61N1/36046A61N1/36142A61N1/3756A61N1/3787A61N1/36057A61N1/37211
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,143,846
App. No.
15/828,950
Granted
Dec 4, 2018
Kind
B2
Abstract

A stimulation system stimulates anatomical targets in a patient for treatment of dry eye. The system may include a controller and a microstimulator. The controller may be implemented externally to or internally within the microstimulator. The components of the controller and microstimulator may be implemented in a single unit or in separate devices. When implemented separately, the controller and microstimulator may communicate wirelessly or via a wired connection. The microstimulator may generate pulses from a controller signal and apply the signal via one or more electrodes to an anatomical target. The microstimulator may not have any intelligence or logic to shape or modify a signal. The microstimulator may be a passive device configured to generate a pulse based on a signal received from the controller. The microstimulator may shape or modify a signal. Waveforms having different frequency, amplitude and period characteristics may stimulate different anatomical targets in a patient.

Claims (19)

1. A method for treating a condition of the eye comprising:

delivering a stimulus to an anatomical target to produce lacrimation, wherein the stimulus is delivered by an implanted microstimulator, wherein the microstimulator comprises a body and one or more electrodes integrated into the body,

wherein at least one of an amplitude and a pulse width of the stimulus is ramped over a ramp period, and wherein the stimulus does not activate pain sensation resulting from delivery of the stimulus.

2. The method of claim 1 , wherein the microstimulator further comprises a passive stimulation circuit.

3. The method of claim 2 , wherein the microstimulator is configured to stimulate the anatomical target via the one or more electrodes in response to a magnetic field.

4. The method of claim 3 , further comprising generating the magnetic field with an external controller.

5. The method of claim 4 , wherein the magnetic field is adjusted based at least in part on input from the user.

6. The method of claim 1 , wherein the microstimulator is pliable.

7. The method of claim 1 , wherein the body of the microstimulator has a length of about 6 mm to about 15 mm, and a width of about 1 mm to about 1.5 mm.

8. The method of claim 1 , wherein the amplitude of the stimulus is ramped from a low amplitude to a higher amplitude over the ramp period.

9. The method of claim 1 , wherein the amplitude of the stimulus is ramped from a high amplitude to a lower amplitude over the ramp period.

10. The method of claim 1 , wherein the pulse width of the stimulus is ramped from a low pulse width to a higher pulse width over the ramp period.

11. The method of claim 1 , wherein the pulse width of the stimulus is ramped from a high pulse width to a lower pulse width over the ramp period.

12. The method of claim 1 , wherein the ramp period is between 1 second and 15 minutes.

13. The method of claim 12 , wherein the ramp period is between 5 seconds and 30 seconds.

14. The method of claim 1 , wherein the stimulus includes a current having a pulse amplitude between about 500 μA and about 25 mA.

15. The method of claim 1 , wherein the stimulus has a pulse frequency between about 2 Hz and about 200 Hz.

16. The method of claim 1 , wherein the stimulus has a pulse width between about 50 μs and about 2700 μs.

17. The method of claim 1 , wherein the stimulus is delivered to one or more nerves that innervates lacrimal gland tissue.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2018
From: ACKERMANN, DOUGLAS MICHAEL; PALANKER, DANIEL; LOUDIN, JAMES DONALD; SMITH, GARRETT CALE; MCCRAY, VICTOR WAYNE; FELKINS, BRANDON MCNARY
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 046808/0518 →
Continuity (8)
Continuation 14816846 · Aug 3, 2015
Continuation 14561107 · Dec 4, 2014
Continuation 13298042 · Nov 16, 2011
Provisional Application 61414293 · Nov 16, 2010
Provisional Application 61433645 · Jan 18, 2011
Provisional Application 61433649 · Jan 18, 2011
Provisional Application 61433652 · Jan 18, 2011
Related Publication 20180154161A1 · Jun 7, 2018
Cited By (1)
US 12,465,776